Keynote speaker “PET is Wonderful” 2018
Gilles D. Tamagnan, PhD, received his doctorate in medicinal chemistry at the University Joseph Fourier in Grenoble, France in 1993. After a postdoctoral fellowship spent on the crystallization of protein, Dr. Tamagnan completed a second postdoctoral fellowship at RBI in Boston, Massachusetts. His research was focused on developing new radioligands for the diagnosis of Parkinson’s disease, and Dr. Tamagnan is a co-inventor of DatScan. He joined the Neuroimaging Program at Yale University in June 1997 to work on the development of new radioligands to study neurodegenerative diseases. Later he moved to Molecular NeuroImaging (MNI) LLC and the Institute for Neurodegenerative Disorders (IND) in 2003, where he worked as Vice President of Chemistry and Translational Research and Laboratory Research and Development Director for several years. Recently Dr Tamagnan has found and is the current Chief Executive Officer of XingImaging LLC, a company focused on developing new radiotracers and providing imaging services.
Keynote speaker “PET is Wonderful” 2018
Paul is Senior Director and Molecular Imaging Lead in UCB Pharma Translational Medicine Neuroscience, Braine l’Alleud, Belgium. He received his BSc. from Paisley College of Technology and PhD from University of Surrey, UK and is MIPEM, MInstP and UK clinical scientist. He was previously Director and Head of Clinical Imaging at Novartis Basel, Switzerland and Director of Neuroimaging at Pfizer Global R&D, Groton, US. He has been leading the application of imaging and biomarkers in translational neurosciences for the past 14 years. His research interests include PET-PK modeling, molecular imaging probe development, neuronal activation as a target and mechanism biomarker, and atrophy measurements using structural MRI. In his earlier career 1990-2004 Paul was physicist in the PET program, Paul Scherrer Institute PET research program in Villigen, Switzerland, assistant professor and medical physicist at University Medical Center Groningen / University of Groningen.A short bio with personal history, key achievements, or an interesting fact.
Keynote speaker “PET is Wonderful” 2019
Prof Knudsen is a Professor of neurobiology, Chief Consultant and Chairmain of the Neurobiology Research Unit and Director of Center for Experimental Medicine Neuropharmacology (NeuroPharm) at the Copenhagen University. Her previous appointments included visiting scientist at NIH and at Stony Brook, USA (1985-90), at Institute of Physiology, Bonn, Germany (1988-89), and at MGH Harvard, Boston (2011-12). As well as, Director of Center for Integrated Molecular Brain Imaging (Cimbi) 2006-15. Prof Knudsen’s scientific interests include blood-brain barrier transport, neurobiology of cerebral blood flow and metabolism and the neurobiology of cerebral neurotransmission with particular emphasis on molecular brain imaging. She has published over 351 scientific papers and reviews, as well as, 28 books/book chapters. Since 1999, Prof Knudsen supervised a total of 24 PhD-students who have defended their PhD thesis. Currently, she is supervising 9 PhD students and mentoring 10 post docs. Prof Knudsen is the Field Editor at the International Journal of Neuropsychopharmacology since 2013. She is a past member of the Board of Directors of the Brain Prize (2013-17) and a current member of the Brain Prize Council (since 2017), a scientific advisor for the Kristian G. Jebsen Foundation, Norway (since 2014) and a board member of the Elsass Foundation (since 2015). Prof Knudsen is also the President-elect of the European College of Neuropsychopharmacology (ECNP) since 2016 and the Chair of the Scientific Advisory Board for The Human Brain Project since 2017.A short bio with personal history, key achievements, or an interesting fact.
Keynote speaker “PET is Wonderful” 2019
Prof Mankoff is the Gerd Muehllehner Professor of Radiology, Vice-Chair for Research in Radiology, and Director of the PET Center at the Perelman School of Medicine at the University of Pennsylvania. He also serves as the Director of the Penn Radiology Department’s PET Center and as the Associate Director for Education and Training for Penn’s Abramson Cancer Center. Prof Mankoff is board-certified in Nuclear Medicine and holds a PhD in Bioengineering focusing on PET instrumentation. He practices Nuclear Medicine at the University of Pennsylvania, with a special interest in oncologic applications of molecular imaging and radionuclide treatment of endocrine tumors and other cancers. Prof Mankoff’s research focuses on molecular imaging of cancer, primarily on breast cancer, and emphasizes therapeutic monitoring, identifying factors mediating therapeutic resistance, and the translation of new methods to clinical trials. He also focuses on imaging methodology and quantitative imaging methods related to molecular cancer imaging. Prof Mankoff is a Komen Scholar for the Susan G. Komen Foundation. He also Chairs the Experimental Imaging Sciences Committee and serves as Co-Chair of the Scientific Program Committee of ECOG-ACRIN. Prof Mankoff is a past member and President of the American Board of Nuclear Medicine and is on the editorial boards of Nuclear Medicine and Biology, Breast Cancer Research, Journal of Nuclear Medicine, The Breast Journal, and Clinical Cancer Research and serves as an Associate Editor for Breast Cancer Research and the Journal of Nuclear Medicine.
Keynote speaker “PET is Wonderful” 2020
Richard E. Carson received his PhD from UCLA in 1983 in Biomathematics. From that time on, he has focused his research on the development and application of mathematical techniques for the study of human beings and non-human primates with Positron Emission Tomography (PET). From 1983 until 2005, he was an integral part of the PET program at the National Institutes of Health, rising to the rank of Senior Scientist. In 2005, Prof Carson joined the faculty of Yale University as Professor of Biomedical Engineering and Diagnostic Radiology. Currently, he is Director of the Yale PET Center and the Director of Graduate Studies in Biomedical Engineering at Yale University.Prof Carson has published over 300 papers in peer-reviewed journals, given over 150 invited lectures and is a member of the editorial board of two of the leading journals in the field of brain PET, the Journal of Nuclear Medicine, and the Journal of Cerebral Blood Flow and Metabolism. Prof Carson has received numerous awards throughout the years in recognition of his ground-breaking contributions to the field of PET imaging, including: the Kuhl-Lassen award (2007), the Ed Hoffman Memorial Award from the Computer and Instrumentation Council of the Society of Nuclear Medicine (2009), Distinguished Investigator Award from the Academy of Radiology Research (2016), and the Edward J. Hoffman Medical Imaging Scientist Award from the IEEE (2017). Prof Carson also gave the prestigious Henry N. Wagner Jr. Lectureship at the Society of Nuclear Medicine and Molecular Imaging annual meeting in Philadelphia in 2018 and was named Fellow of the IEEE in 2019.
Keynote speaker “PET is Wonderful” 2021
Tim McCarthy is the Vice-President and Head of Digital Medicine & Translational Imaging in Early Clinical Development at Pfizer. This team is dedicated to applying sensor- and non-invasive imaging-based technologies to clinical development programs across the enterprise. Tim has a background in Positron Emission Tomography, which he obtained during his time as a faculty member in Radiology at Washington University School of Medicine in St Louis. In 2001 he joined Pharmacia to pursue his interests in applying imaging to drug development. Following the Pfizer acquisition, Tim was appointed to lead a team dedicated to Clinical Imaging. In 2013, he expanded his role to include preclinical imaging and established a translational imaging team that works across the continuum of drug development. In 2018, he was appointed to his current role which expands his responsibilities to include the evaluation and deployment of novel wearables and sensor technologies in clinical development. Outside of Pfizer, Tim has been active in the imaging community; he was President of the Academy of Molecular Imaging (AMI) from 2008-11, prior to the formation of the World Molecular Imaging Society (WMIS). He was a founding director and past president of the Society of Non-Invasive Imaging in Drug Development (SNIDD) and a Fellow of the WMIS. Tim received his B.Sc. and Ph.D. in Organic Chemistry from the University of Liverpool, UK and his MBA from Washington University in St Louis.